title: Coordinate regulation of ganglioside glycosyltransferases in differentiating NG108-15 neuroblastoma x glioma cells.
abstract: The enzymatic basis for ganglioside regulation during differentiation of NG108-15 mouse neuroblastoma x rat glioma hybrid cells was studied. This cell line contains four gangliosides that lie along the same biosynthetic pathway: GM3, GM2, GM1, and GD1a. Chemically induced neuronal differentiation of NG108-15 cells led to an 80% drop in the steady-state level of their major ganglioside, GM3, a sixfold increase in the level of a minor ganglioside, GM2 (which became the predominant ganglioside of differentiated cells); and relatively little change in the levels of GM1 and GD1a, which lie further along the same biosynthetic pathway. The enzymatic basis for this selective change in ganglioside expression was investigated by measuring the activity of two glycosyltransferases involved in ganglioside biosynthesis. UDP-N-acetylgalactosamine: GM3 N-acetylgalactosaminyltransferase (GM2-synthetase) activity increased fivefold during butyrate-induced differentiation, whereas UDP-galactose: GM2 galactosyltransferase (GM1-synthetase) activity decreased to 10% of its control level. Coordinate regulation of these two glycosyltransferases appears to be primarily responsible for the selective increase of GM2 expression during NG108-15 differentiation.
authors.affiliation: Department of Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
authors.forename: K M
authors.initials: KM
authors.lastname: Walton
authors.forename: R L
authors.initials: RL
authors.lastname: Schnaar
mesh_terms: D000527:Alprostadil / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002454:Cell Differentiation; D005677:G(M1) Ganglioside / Q000032:analysis / Q000378:metabolism; D005678:G(M2) Ganglioside / Q000032:analysis / Q000378:metabolism; D005679:G(M3) Ganglioside / Q000032:analysis / Q000378:metabolism; D005700:Galactosyltransferases / Q000378:metabolism*; D051147:Ganglioside Galactosyltransferase; D005732:Gangliosides / Q000032:analysis / Q000378:metabolism; D005910:Glioma / Q000201:enzymology*; D006822:Hybrid Cells / Q000201:enzymology*; D007700:Kinetics; D013058:Mass Spectrometry; D051379:Mice; D017350:N-Acetylgalactosaminyltransferases; D009447:Neuroblastoma / Q000201:enzymology*; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D000097763:Polypeptide N-acetylgalactosaminyltransferase
chemical_list: D000527:Alprostadil; D003994:Bucladesine; D005677:G(M1) Ganglioside; D005678:G(M2) Ganglioside; D005679:G(M3) Ganglioside; D005700:Galactosyltransferases; D051147:Ganglioside Galactosyltransferase; D005732:Gangliosides; D017350:N-Acetylgalactosaminyltransferases; D013806:Theophylline; D000097763:Polypeptide N-acetylgalactosaminyltransferase; C021298:ganglioside, GD1a; C023220:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase